Literature DB >> 14522149

Inflammation, degeneration and regeneration in the injured spinal cord: insights from DNA microarrays.

Florence M Bareyre1, Martin E Schwab.   

Abstract

GeneChip microarrays have recently been introduced to the field of neurobiology to identify and monitor the expression levels of thousands of genes simultaneously. This powerful technique is now used for studying the pathophysiology of CNS injuries including spinal cord lesions. Early stages after injury are characterized by the strong upregulation of genes involved in transcription and inflammation and a general downregulation of structural proteins and proteins involved in neurotransmission. Later, an increase in the expression of growth factors, axonal guidance factors, extracellular matrix molecules and angiogenic factors reflects the attempts for repair, while upregulation of stress genes and proteases and downregulation of cytoskeletal and synaptic mRNA reflect the struggle of the tissue to survive. DNA microarrays have the potential to aid discovery of new targets for neuroprotective or restorative therapeutic approaches

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14522149     DOI: 10.1016/j.tins.2003.08.004

Source DB:  PubMed          Journal:  Trends Neurosci        ISSN: 0166-2236            Impact factor:   13.837


  88 in total

Review 1.  Biomaterial Approaches to Modulate Reactive Astroglial Response.

Authors:  Jonathan M Zuidema; Ryan J Gilbert; Manoj K Gottipati
Journal:  Cells Tissues Organs       Date:  2018-12-05       Impact factor: 2.481

2.  MicroRNA dysregulation following spinal cord contusion: implications for neural plasticity and repair.

Authors:  E R Strickland; M A Hook; S Balaraman; J R Huie; J W Grau; R C Miranda
Journal:  Neuroscience       Date:  2011-04-07       Impact factor: 3.590

Review 3.  Reactive astrogliosis after spinal cord injury-beneficial and detrimental effects.

Authors:  Soheila Karimi-Abdolrezaee; Rohini Billakanti
Journal:  Mol Neurobiol       Date:  2012-06-09       Impact factor: 5.590

4.  Proof-of Concept that an Acute Trophic Factors Intervention After Spinal Cord Injury Provides an Adequate Niche for Neuroprotection, Recruitment of Nestin-Expressing Progenitors and Regeneration.

Authors:  Warin Krityakiarana; Paul M Zhao; Kevin Nguyen; Fernando Gomez-Pinilla; Naiphinich Kotchabhakdi; Jean de Vellis; Araceli Espinosa-Jeffrey
Journal:  Neurochem Res       Date:  2016-02-17       Impact factor: 3.996

5.  The tumor suppressor protein p53 is required for neurite outgrowth and axon regeneration.

Authors:  Simone Di Giovanni; Chad D Knights; Mahadev Rao; Alexander Yakovlev; Jeannette Beers; Jason Catania; Maria Laura Avantaggiati; Alan I Faden
Journal:  EMBO J       Date:  2006-08-31       Impact factor: 11.598

6.  Rapid induction of genes associated with tissue protection and neural development in contused adult spinal cord after radial glial cell transplantation.

Authors:  Yu-Wen Chang; Loyal A Goff; Hedong Li; Noriko Kane-Goldsmith; Evangeline Tzatzalos; Ronald P Hart; Wise Young; Martin Grumet
Journal:  J Neurotrauma       Date:  2009-07       Impact factor: 5.269

Review 7.  Cellular transplantation strategies for spinal cord injury and translational neurobiology.

Authors:  Paul J Reier
Journal:  NeuroRx       Date:  2004-10

8.  Protective role of microRNA-219-5p inhibitor against spinal cord injury via liver receptor homolog-1/Wnt/β-catenin signaling pathway regulation.

Authors:  Jie Li; Liqiang Li; Yong Shen
Journal:  Exp Ther Med       Date:  2018-02-01       Impact factor: 2.447

9.  FK506 Attenuates the Inflammation in Rat Spinal Cord Injury by Inhibiting the Activation of NF-κB in Microglia Cells.

Authors:  Gang Liu; Gentao Fan; Guodong Guo; Wenbo Kang; Dongsheng Wang; Bin Xu; Jianning Zhao
Journal:  Cell Mol Neurobiol       Date:  2016-08-29       Impact factor: 5.046

Review 10.  Accelerating locomotor recovery after incomplete spinal injury.

Authors:  Brian K Hillen; James J Abbas; Ranu Jung
Journal:  Ann N Y Acad Sci       Date:  2013-03       Impact factor: 5.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.